Abstract

Abstract. Diabetes mellitus is a prevalent and severe metabolic disorder disease that poses significant health risks globally, leading to substantial healthcare burdens. Recent days, advancements in artificial intelligence (AI) have markedly enhanced the accuracy and efficiency of diabetes outcome predicted by machine learning (ML), offering a promising approach for early intervention and treatment. This paper evaluates several advanced ML models, including Random Forest (RF), Support Vector Machine (SVM), and Neural Networks techniques based on neural networks. Each model's strengths and limitations are discussed, highlighting the improvements in predictive performance and diagnostic precision. Despite these advancements, the field faces ongoing challenges related to ethical considerations and data scale, which impact ML application in healthcare from both technical and moral aspects. Future efforts should focus on these challenges by promoting data sharing and integration while safeguarding privacy. Through these endeavors, we aim to advance the field of diabetes prediction and improve patient care.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.